venglustat GZ402671 - SAR402671, IMIGLUCERASE, venglustat GZ402671 - SAR402671
PDY13949
Phase 2 small_molecule active
Quick answer
venglustat GZ402671 - SAR402671, IMIGLUCERASE, venglustat GZ402671 - SAR402671 for Gaucher disease type 3, Gaucher disease type 1 is a Phase 2 program (small_molecule) at Genzyme Europe B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genzyme Europe B.V.
- Indication
- Gaucher disease type 3, Gaucher disease type 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active